Stock Screener
Stock Research
Market Indexes
Precious Metals
Energy
Commodities
Interest Rates
Economy
Global Metrics

Indaptus Therapeutics - 13 Year Stock Price History | INDP

Historical daily share price chart and data for Indaptus Therapeutics since 2012 adjusted for splits and dividends. The latest closing stock price for Indaptus Therapeutics as of May 06, 2025 is 0.43.
  • The all-time high Indaptus Therapeutics stock closing price was 8680.00 on November 23, 2016.
  • The Indaptus Therapeutics 52-week high stock price is 3.10, which is 620.9% above the current share price.
  • The Indaptus Therapeutics 52-week low stock price is 0.43, which is 0% below the current share price.
  • The average Indaptus Therapeutics stock price for the last 52 weeks is 1.33.
For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
  
Indaptus Therapeutics Historical Annual Stock Price Data
Year Average Stock Price Year Open Year High Year Low Year Close Annual % Change
2025 0.7215 0.8548 1.0100 0.4300 0.4300 -48.94%
2024 1.7861 1.7600 2.8000 0.8359 0.8421 -52.15%
2023 2.1087 1.5400 3.9500 1.5109 1.7600 21.38%
2022 2.9844 6.1700 6.1700 1.3700 1.4500 -74.56%
2021 12.7664 14.5200 31.4000 5.2100 5.7000 -58.70%
2020 22.6956 39.4000 44.9600 9.1600 13.8000 -65.50%
2019 303.5696 637.6000 729.6000 34.7200 40.0000 -93.37%
2018 431.3597 484.0000 650.4000 292.0000 603.2000 46.41%
2017 787.8758 420.0000 8640.0000 344.0000 412.0000 -9.65%
2016 614.7955 400.0000 8680.0000 251.2000 456.0000 6.34%
2015 462.7768 480.0000 495.2000 428.8000 428.8000 0.00%
2013 32.0000 32.0000 32.0000 32.0000 32.0000 23.19%
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $0.007B $0.000B
Indaptus Therapeutics approach is based on the hypothesis which efficient activation of both innate and adaptive immune cells and associated anti-tumor and anti-viral immune responses will require a multi-targeted package of immune system activating signals. Indaptus Therapeutics, formerly known as Intec Parent Inc., is based in NEW YORK.
Stock Name Country Market Cap PE Ratio
Chugai Pharmaceutical (CHGCY) Japan $99.323B 37.26
Zoetis (ZTS) United States $70.523B 26.70
Daiichi Sankyo, - (DSNKY) Japan $49.922B 25.40
Takeda Pharmaceutical (TAK) Japan $48.938B 10.83
Summit Therapeutics (SMMT) United States $20.810B 0.00
Sandoz Group AG (SDZNY) Switzerland $19.664B 0.00
Merck (MKKGY) Germany $18.359B 15.19
Shionogi (SGIOY) Japan $14.547B 14.57
United Therapeutics (UTHR) United States $13.473B 11.92
Neurocrine Biosciences (NBIX) United States $10.858B 37.20
IPSEN (IPSEY) France $9.940B 0.00
Orion OYJ (ORINY) Finland $9.075B 24.54
Corcept Therapeutics (CORT) United States $7.841B 63.74
Madrigal Pharmaceuticals (MDGL) United States $6.803B 0.00
Stevanato Group S.p.A (STVN) Italy $6.702B 42.56
Ono Pharmaceutical (OPHLF) Japan $5.988B 12.26
Hikma Pharmaceuticals Plc (HKMPF) United Kingdom $5.813B 0.00
Ionis Pharmaceuticals (IONS) United States $5.355B 0.00
Grifols, S.A (GRFS) Spain $5.122B 0.00
Soleno Therapeutics (SLNO) United States $3.817B 0.00
Crinetics Pharmaceuticals (CRNX) United States $3.151B 0.00
Catalyst Pharmaceuticals (CPRX) United States $2.964B 12.03
Hypermarcas (HYPMY) Brazil $2.350B 15.46
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $2.337B 12.78
BioCryst Pharmaceuticals (BCRX) United States $2.308B 0.00
NewAmsterdam Pharma (NAMS) Netherlands $2.223B 0.00
Recursion Pharmaceuticals (RXRX) United States $1.911B 0.00
Centessa Pharmaceuticals (CNTA) United Kingdom $1.807B 0.00
Indivior (INDV) United States $1.641B 6.96
Guardian Pharmacy Services (GRDN) United States $1.610B 0.00
Evotec AG (EVO) Germany $1.481B 0.00
ARS Pharmaceuticals (SPRY) United States $1.400B 178.25
Dyne Therapeutics (DYN) United States $1.344B 0.00
Ocular Therapeutix (OCUL) United States $1.231B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $1.129B 45.89
Enliven Therapeutics (ELVN) United States $1.000B 0.00
Harrow (HROW) United States $0.907B 0.00
Ardelyx (ARDX) United States $0.894B 0.00
Collegium Pharmaceutical (COLL) United States $0.893B 4.74
Avadel Pharmaceuticals (AVDL) Ireland $0.874B 0.00
Xencor (XNCR) United States $0.763B 0.00
AleAnna (ANNA) United States $0.743B 0.00
Cronos Group (CRON) Canada $0.732B 0.00
Xeris Biopharma Holdings (XERS) United States $0.726B 0.00
Organogenesis (ORGO) United States $0.675B 0.00
KalVista Pharmaceuticals (KALV) United States $0.651B 0.00
Akebia Therapeutics (AKBA) United States $0.613B 0.00
Bioventus (BVS) United States $0.576B 14.96
Savara (SVRA) United States $0.567B 0.00
Relay Therapeutics (RLAY) United States $0.566B 0.00
USANA Health Sciences (USNA) United States $0.546B 11.71
Regulus Therapeutics (RGLS) United States $0.520B 0.00
Theravance Biopharma (TBPH) Cayman Islands $0.515B 0.00
CytoDyn (CYDY) United States $0.511B 0.00
Verve Therapeutics (VERV) United States $0.460B 0.00
Amylyx Pharmaceuticals (AMLX) United States $0.459B 0.00
Elite Pharmaceuticals (ELTP) United States $0.455B 0.00
Zevra Therapeutics (ZVRA) United States $0.437B 0.00
Altimmune (ALT) United States $0.418B 0.00
Tourmaline Bio (TRML) United States $0.409B 0.00
Siga Technologies (SIGA) United States $0.386B 6.59
Oruka Therapeutics (ORKA) United States $0.374B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.341B 20.33
Heron Therapeutics (HRTX) United States $0.325B 0.00
Aquestive Therapeutics (AQST) United States $0.281B 0.00
Avita Medical (RCEL) United States $0.243B 0.00
Wellgistics Health (WGRX) United States $0.237B 0.00
Nature's Sunshine Products (NATR) United States $0.231B 27.17
ProKidney (PROK) United States $0.220B 0.00
Esperion Therapeutics (ESPR) United States $0.208B 26.25
OmniAb (OABI) United States $0.205B 0.00
MediWound (MDWD) Israel $0.191B 0.00
Larimar Therapeutics (LRMR) United States $0.172B 0.00
Nanobiotix S.A (NBTX) France $0.167B 0.00
Korro Bio (KRRO) United States $0.166B 0.00
4D Molecular Therapeutics (FDMT) United States $0.165B 0.00
Profound Medical (PROF) Canada $0.164B 0.00
Aldeyra Therapeutics (ALDX) United States $0.162B 0.00
Journey Medical (DERM) United States $0.159B 0.00
Inhibikase Therapeutics (IKT) United States $0.155B 0.00
Ironwood Pharmaceuticals (IRWD) United States $0.150B 46.38
Lexeo Therapeutics (LXEO) United States $0.148B 0.00
Aclaris Therapeutics (ACRS) United States $0.139B 0.00
Protara Therapeutics (TARA) United States $0.131B 0.00
Lyell Immunopharma (LYEL) United States $0.128B 0.00
Nektar Therapeutics (NKTR) United States $0.128B 0.00
Tonix Pharmaceuticals Holding (TNXP) United States $0.126B 0.00
Innate Pharma SA (IPHYF) France $0.122B 0.00
Enanta Pharmaceuticals (ENTA) United States $0.116B 0.00
OptiNose (OPTN) United States $0.095B 0.00
Cardiol Therapeutics (CRDL) Canada $0.095B 0.00
VAXART, INC (VXRT) United States $0.095B 0.00
Achieve Life Sciences (ACHV) Canada $0.092B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.091B 0.00
Arch Biopartners (ACHFF) Canada $0.083B 0.00
Champions Oncology (CSBR) United States $0.083B 13.68
Galectin Therapeutics (GALT) United States $0.083B 0.00
Fractyl Health (GUTS) United States $0.080B 0.00
Unicycive Therapeutics (UNCY) United States $0.078B 0.00
Cassava Sciences (SAVA) United States $0.077B 0.00
Telomir Pharmaceuticals (TELO) United States $0.076B 0.00
ESSA Pharma (EPIX) Canada $0.076B 0.00
Context Therapeutics (CNTX) United States $0.075B 0.00
Dominari Holdings (DOMH) United States $0.074B 0.00
Pyxis Oncology (PYXS) United States $0.074B 0.00
Nutriband (NTRB) United States $0.072B 0.00
Inotiv (NOTV) United States $0.069B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.062B 0.00
Vivani Medical (VANI) United States $0.061B 0.00
Karyopharm Therapeutics (KPTI) United States $0.061B 0.00
Gain Therapeutics (GANX) United States $0.060B 0.00
Metagenomi (MGX) United States $0.059B 0.00
Allergy Therapeutics (AGYTF) United Kingdom $0.059B 0.00
Assertio Holdings (ASRT) United States $0.058B 0.00
Avalo Therapeutics (AVTX) United States $0.054B 0.00
ElectroCore (ECOR) United States $0.049B 0.00
PMV Pharmaceuticals (PMVP) United States $0.049B 0.00
Century Therapeutics (IPSC) United States $0.048B 0.00
Acrivon Therapeutics (ACRV) United States $0.045B 0.00
Mural Oncology (MURA) Ireland $0.044B 0.00
Verrica Pharmaceuticals (VRCA) United States $0.041B 0.00
Reviva Pharmaceuticals Holdings (RVPH) United States $0.040B 0.00
SCYNEXIS (SCYX) United States $0.038B 0.00
Iterum Therapeutics (ITRM) Ireland $0.037B 0.00
Prelude Therapeutics (PRLD) United States $0.036B 0.00
Rafael Holdings (RFL) United States $0.036B 0.00
NRx Pharmaceuticals (NRXP) United States $0.035B 0.00
Surrozen (SRZN) United States $0.034B 0.00
FibroGen (FGEN) United States $0.032B 0.00
PolyPid (PYPD) Israel $0.029B 0.00
Tempest Therapeutics (TPST) United States $0.025B 0.00
Enlivex Therapeutics (ENLV) Israel $0.025B 0.00
CASI Pharmaceuticals (CASI) China $0.024B 0.00
VYNE Therapeutics (VYNE) United States $0.022B 0.00
BioVie (BIVI) United States $0.021B 0.00
Jupiter Neurosciences (JUNS) United States $0.021B 0.00
Mannatech (MTEX) United States $0.019B 7.60
DURECT (DRRX) United States $0.018B 0.00
Lipocine (LPCN) United States $0.018B 0.00
GlycoMimetics (GLYC) United States $0.018B 0.00
Natural Alternatives (NAII) United States $0.017B 0.00
TherapeuticsMD (TXMD) United States $0.016B 0.00
Vivos Therapeutics (VVOS) United States $0.015B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.014B 0.00
MEI Pharma (MEIP) United States $0.014B 0.00
Relmada Therapeutics (RLMD) United States $0.013B 0.00
Cosmos Health (COSM) United States $0.012B 0.00
ProPhase Labs (PRPH) United States $0.012B 0.00
Minerva Neurosciences (NERV) United States $0.012B 9.00
Scienture Holdings (SCNX) United States $0.012B 0.00
Talphera (TLPH) United States $0.011B 0.00
BioLineRx (BLRX) Israel $0.011B 0.00
Plus Therapeutics (PSTV) United States $0.011B 0.00
Ernexa Therapeutics (ERNA) United States $0.010B 0.00
Kiora Pharmaceuticals (KPRX) United States $0.010B 3.14
TransCode Therapeutics (RNAZ) United States $0.010B 0.00
Carisma Therapeutics (CARM) United States $0.009B 0.00
Mangoceuticals (MGRX) United States $0.009B 0.00
Biomerica (BMRA) United States $0.009B 0.00
Phio Pharmaceuticals (PHIO) United States $0.009B 0.00
Addex Therapeutics (ADXN) Switzerland $0.009B 0.00
Ainos (AIMD) United States $0.008B 0.00
Nuvilex (PMCB) United States $0.008B 0.00
Traws Pharma (TRAW) United States $0.008B 0.00
Citius Pharmaceuticals (CTXR) United States $0.008B 0.00
Jaguar Animal Health (JAGX) United States $0.008B 0.00
XTL Biopharmaceuticals (XTLB) Israel $0.008B 0.00
Lyra Therapeutics (LYRA) United States $0.007B 0.00
NLS Pharmaceutics (NLSP) Switzerland $0.006B 0.00
Conduit Pharmaceuticals (CDT) United States $0.006B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.006B 0.00
Klotho Neurosciences (KLTO) United States $0.005B 0.00
Alaunos Therapeutics (TCRT) United States $0.005B 0.00
Aptorum Group (APM) United Kingdom $0.005B 0.00
Xenetic Biosciences (XBIO) United States $0.004B 0.00
SciSparc (SPRC) Israel $0.004B 0.00
Clearmind Medicine (CMND) Canada $0.004B 0.00
CERo Therapeutics Holdings (CERO) United States $0.004B 0.00
XORTX Therapeutics (XRTX) Canada $0.004B 0.00
Quoin Pharmaceuticals (QNRX) United States $0.004B 0.00
Redhill Biopharma (RDHL) Israel $0.004B 0.00
InMed Pharmaceuticals (INM) Canada $0.004B 0.00
60 Degrees Pharmaceuticals (SXTP) United States $0.003B 0.00
Qualigen Therapeutics (QLGN) United States $0.003B 0.00
Incannex Healthcare (IXHL) Australia $0.002B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.002B 0.00
PainReform (PRFX) Israel $0.002B 0.00
TNF Pharmaceuticals (TNFA) United States $0.002B 0.00
Shuttle Pharmaceuticals Holdings (SHPH) United States $0.002B 0.00
Salarius Pharmaceuticals (SLRX) United States $0.002B 0.00
SHINECO (SISI) China $0.001B 0.00
Heatwurx (PCSA) United States $0.001B 0.00
China SXT Pharmaceuticals (SXTC) China $0.001B 0.00
Petros Pharmaceuticals (PTPI) United States $0.000B 0.00
Universe Pharmaceuticals INC (UPC) China $0.000B 0.00
Aditxt (ADTX) United States $0.000B 0.00
4D Pharma (LBPS) United Kingdom $0.000B 0.00
Patheon (PTHN) Netherlands $0.000B 0.00
RVL Pharmaceuticals (RVLP) United States $0.000B 0.00
Silence Therapeutics (SLN) United Kingdom $0.000B 0.00